Skip to search.
 TSX Up0.07% TSX Ventures 0.00%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

8.03 0.00(0.00%) May 24, 4:00PM EDT|After Hours : 8.03 Up 0.00 (0.02%) May 24, 4:35PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2013-03-302012-12-302012-09-292012-06-29
Total Revenue 7,000   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit 7,000   -   -   -  
Operating Expenses
Research Development6,239  4,753  3,768  3,726  
Selling General and Administrative2,919  1,925  1,758  1,973  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,158) (6,678) (5,526) (5,699)
Income from Continuing Operations
Total Other Income/Expenses Net103  50  51  4,195  
Earnings Before Interest And Taxes(2,055)(6,628)(5,475)(4,143)
Interest Expense -   -   -   -  
Income Before Tax(2,055)(6,628)(5,475)(4,143)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,055)(9,267)(5,475)(1,504)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,055) (6,628) (5,475) (1,504)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,055) (6,628) (5,475) (1,504)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.